跳至主要内容
临床试验/NCT03057041
NCT03057041已完成不适用

Intranasal Fentanyl for Pain Control During First-Trimester Uterine Aspiration: A Randomized Controlled Trial

University of Hawaii2 个研究点 分布在 1 个国家目标入组 107 人开始时间: 2017年3月23日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
107
试验地点
2
主要终点
Pain during uterine aspiration

研究概览

简要总结

Intranasal fentanyl has been found to be safe and effective in the reduction of pain among pediatric and adult populations. The investigators hypothesize that patients who receive 100 mcg of intranasal fentanyl for pain control before first-trimester uterine aspiration will report lower pain scores than those who receive placebo. The investigators will test this hypothesis using a randomized, double-blind, placebo-controlled trial comparing pain reported during uterine aspiration between patients who receive either intranasal fentanyl or intranasal saline prior to the procedure.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)

入排标准

年龄范围
14 Years 至 —(Child, Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Seeking office based uterine aspiration
  • Gestational age at 14 weeks or less
  • Age 14 years or older with parental consent to participate in this research study if 14-17 years old
  • Able to read, speak, and understand English
  • Ability to understand materials and consent forms

排除标准

  • Seeking medical abortion, operating room based surgical abortion, or operating room based miscarriage management
  • Gestational age greater than 14 weeks
  • Age less than 14 years old
  • Inability to read, speak, and understand English
  • Current incarceration
  • Weight less than 40kg
  • Self-reported or documentation of significant cardiopulmonary disease
  • Self-reported or documentation of alcohol or substance dependence or abuse
  • Contraindications, relative contraindication to fentanyl use

研究组 & 干预措施

Fentanyl

Experimental

干预措施: Fentanyl (Drug)

Placebo

Placebo Comparator

干预措施: placebo (Drug)

结局指标

主要结局

Pain during uterine aspiration

时间窗: During uterine aspiration or immediately after uterine aspiration

Self reported on 100 mm VAS

次要结局

  • Post-procedural pain(approximately 15 minutes after procedure end)
  • Patient satisfaction with procedural pain control(approximately 15 minutes after procedure ends)

研究者

发起方
University of Hawaii
申办方类型
Other
责任方
Sponsor

研究点 (2)

Loading locations...

相似试验